🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 8148352

    Antimicrobial therapy for bacterial infections

    The Regents of the University of California · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8137960

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8133496

    Compositions and methods for diagnosing and treating urinary tract infections

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8128921

    Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination

    UNIVERSITY OF CONNECTICUT · Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8124110

    Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8124109

    Vault compositions for immunization against chlamydia genital infection

    The Regents of the University of California · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8124592

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8110192

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8106027

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8106026

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8105607

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8092812

    Methods and compositions for immunization against chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8088729

    Anti-viral griffithsin compounds, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8076372

    Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The Government of the United States · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8076100

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8076099

    Biomarkers of Francisella infection

    The Board of Regents of the University of Texas System · Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8071107

    Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

    The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8067202

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8044185

    Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8039001

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8029809

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8030307

    Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8025891

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8021671

    Pro-apoptotic bacterial vaccines to enhance cellular immune responses

    The United States of America as represented by the Department of Veteran Affairs · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8021673

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8022190

    Immuno-molecules containing viral proteins, compositions thereof and methods of using

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8012493

    Malaria vaccines

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8013006

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8003685

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8003091

    Pharmaceutical compositions comprising purified intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7999074

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7999001

    Antiviral compounds and methods of using thereof

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7994143

    Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates

    The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7994226

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7994139

    Antiviral therapeutic agents

    BioCryst Pharmaceuticals, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7989430

    Antibacterial agents

    Regents of the University of Minnesota · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7985769

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7973069

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7968298

    Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7956177

    dsRNA compositions and methods for treating HPV infection

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7947822

    HIV vaccines based on Env of multiple clades of HIV

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7935357

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7927793

    Cell lines and host nucleic acid sequences related to infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7928080

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.